BPG is committed to discovery and dissemination of knowledge
Letter to the Editor
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Nephrol. Mar 25, 2025; 14(1): 101930
Published online Mar 25, 2025. doi: 10.5527/wjn.v14.i1.101930
Current understanding of adult nephrotic syndrome: Minimal change disease
Krishna Kumar Govindarajan
Krishna Kumar Govindarajan, Department of Pediatric Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry 605006, India
Author contributions: Govindarajan KK conceptualized and reviewed the manuscript; the author read and approved the final version of the manuscript to be published.
Conflict-of-interest statement: The author declares no conflict of interest in publishing the manuscript.
Corresponding author: Krishna Kumar Govindarajan, FACS, MBBS, MCh, MD, MNAMS, Professor, Department of Pediatric Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, JIPMER Campus Road, Gorimedu, Dhanvantari Nagar, Puducherry 605006, India. kkpeds@gmail.com
Received: October 8, 2024
Revised: December 24, 2024
Accepted: January 7, 2025
Published online: March 25, 2025
Processing time: 111 Days and 2.1 Hours
Abstract

The underlying molecular changes that result in minimal change disease (nephrotic syndrome) require an in-depth analysis. Current molecular studies have shown the involvement of zinc fingers and homeobox transcriptional factors in its pathogenesis. The application of therapeutic drugs relies on understanding the cascade of molecular events to determine their efficacy in managing the clinical condition.

Keywords: Minimal change disease; Nephrotic syndrome; Hyposialylation; Podocytes; Albuminuria

Core Tip: Minimal change disease (MCD) represents a unique type of nephrotic syndrome in adults. MCD pathogenesis has been previously attributed to several mechanisms, though they did not explain all of the features and therapeutic implications of MCD. The recent identification of zinc fingers and homeobox transcriptional factors has provided a new dimension to understand and provide better management in MCD.